HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of topical corticosteroids in the management of Acanthamoeba keratitis.

AbstractPURPOSE:
To clarify the role of topical corticosteroids in the management of Acanthamoeba keratitis.
METHODS:
The records of 38 patients diagnosed with Acanthamoeba keratitis at three institutions were retrospectively reviewed.
RESULTS:
After medical therapy alone, patients diagnosed within 1 month of symptom onset had an increased likelihood of being cured (p = 0.02) and attaining visual acuity of 20/60 or better (p < 0.01). Fourteen (73.7%) of 19 patients treated with topical corticosteroids at any time were cured after antiamoebal therapy alone, whereas five (26.3%) patients required penetrating keratoplasty for either persistent infection (n = 3) or perforation (n = 2). The mean antiamoebal therapy duration, excluding duration after keratoplasty if applicable, was 38.5 weeks. Thirteen (76.5%) of 17 patients treated with antiamoebal therapy without topical corticosteroids were medically cured, whereas four (23.5%) required penetrating keratoplasty for either persistent infection (n = 2) or perforation (n = 2). The mean antiamoebal therapy duration was 20 weeks. Although the mean antiamoebal therapy duration in the steroid-treated group was significantly longer than that in the non-steroid-treated group (p = 0.02), outcome after medical therapy between the groups was not significantly different.
CONCLUSIONS:
Topical corticosteroids were not associated with a higher rate of medical treatment failure in patients with Acanthamoeba keratitis. Rather, poor outcome was significantly related to diagnostic delays. Therefore prudent use of corticosteroids in selected patients with severe pain not responsive to analgesics or severe corneal or anterior chamber inflammation appears justified.
AuthorsD H Park, D A Palay, S M Daya, R D Stulting, J H Krachmer, E J Holland
JournalCornea (Cornea) Vol. 16 Issue 3 Pg. 277-83 (May 1997) ISSN: 0277-3740 [Print] United States
PMID9143798 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Infective Agents, Local
  • Antiprotozoal Agents
  • Glucocorticoids
Topics
  • Acanthamoeba (isolation & purification)
  • Acanthamoeba Keratitis (drug therapy, etiology, surgery)
  • Administration, Topical
  • Adolescent
  • Adult
  • Aged
  • Animals
  • Anti-Infective Agents, Local (administration & dosage, therapeutic use)
  • Antiprotozoal Agents (administration & dosage, therapeutic use)
  • Cornea (drug effects, parasitology, pathology)
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glucocorticoids (administration & dosage, therapeutic use)
  • Humans
  • Keratoplasty, Penetrating (pathology)
  • Male
  • Middle Aged
  • Recurrence
  • Retrospective Studies
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: